Jazz Pharmaceuticals plc Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Jazz Pharmaceuticals plc (JAZZ) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $3.91 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-02-24
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $3.91M, a 6.88% increase from fiscal 2023.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $3.66M, a 16.55% decline from fiscal 2022.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $4.39M, a 127.66% increase from fiscal 2021.
- Jazz Pharmaceuticals plc effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $1.93M, a 18.44% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $3.91M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $3.66M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $4.39M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $1.93M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $1.63M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $1.12M 10-K · filed 2022-03-01 | |
| 2014-12-31 | -$497.00K 10-K · filed 2015-02-24 | |
| 2013-12-31 | $2.83M 10-K · filed 2015-02-24 | $4.35M 10-K · filed 2014-02-25 |
| 2012-12-31 | -$132.00K 10-K · filed 2015-02-24 | |
| 2011-12-31 | $353.00K 10-K · filed 2014-02-25 | |
| 2010-12-31 | -$80.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |